Bcl-2, Raf-1 and mitochondrial regulation of apoptosis

BioFactors

Volumn 8, Issue 1-2, 1998, Pages 13-16

  Wang, Hong Gang ^a,b   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PROTEIN BCL 2; RAF PROTEIN; RECOMBINANT PROTEIN;

APOPTOSIS; CELL PROTECTION; CONFERENCE PAPER; HUMAN; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; ENZYME ACTIVE SITE; GENETIC TRANSFECTION; HOMEOSTASIS; INTRACELLULAR MEMBRANE; METABOLISM; PHYSIOLOGY; POINT MUTATION; SITE DIRECTED MUTAGENESIS;

ANIMALS; APOPTOSIS; CATALYTIC DOMAIN; CELL LINE; HOMEOSTASIS; HUMANS; INTRACELLULAR MEMBRANES; MITOCHONDRIA; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-RAF; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0031596370     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520080103     Document Type: Conference Paper

References (15)

1. C. Borner, I. Martinou, C. Mattmann, M. Irmler, E. Scharer, J.-C. Martinou and J. Tschopp, The protein Bcl-2-alpha does not require membrane attachment, but two conserved domains to suppress apoptosis, J. Cell Biol. 126 (1994), 1059-1068.
2. M. Hanada, C. Aimé-Sempé, T. Sato and J.C. Reed, Structure-function analysis of Bcl-2 protein: identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax, J. Biol. Chem. 270 (1995), 11962-11968.
3. J.J. Hunter, B.L. Bond and T.G. Parslow, Functional dissection of the human Bcl-2 protein: sequence requirements for inhibition of apoptosis, Mol. Cell Biol. 16 (1996), 877-883.
4. J.C. Reed, Bcl-2 and the regulation of programmed cell death, J. Cell Biol. 124 (1994), 1-6.
5. J.C. Reed, Towards a molecular understanding of Bcl-2 family proteins, Nature (1997, in press).
6. T. Sato, M. Hanada, S. Bodrug, S. Irie, N. Iwama, L. Boise, C. Thompson, L. Fong, H.-G. Wang and J.C. Reed, Investigation of interactions between members of the Bcl-2 protein family using yeast two-hybrid system, Proc. Natl. Acad. Sci. USA 91 (1994), 9238-9242.
7. 2+-activated cell death in mammalian cells, J. Cell Biol. 131 (1995), 735-743.
8. F. Shibasaki, E. Kondo, T. Akagi and F. McKeon, Suppression of signalling through NF-AT by interactions between calcineurin and Bcl-2, Nature 386 (1997), 728-731.
9. H.-G. Wang, T. Miyashita, S. Takayama, T. Sato, T. Torigoe, S. Krajewski, S. Tanaka, L. Hovey, J. Troppmair, U.R. Rapp and J.C. Reed, Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase, Oncogene 9 (1994), 2751-2756.
10. H.-G. Wang, U.R. Rapp and J.C. Reed, Bcl-2 targets the protein kinase Raf-1 to mitochondria, Cell 87 (1996), 629-638.
11. H.-G. Wang, S. Takayama, U.R. Rapp and J.C. Reed, Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1, Proc. Natl. Acad. Sci. USA 93 (1996), 7063-7068.
12. L and Bcl-2, displaces Bax and promotes cell death, Cell 80 (1995), 285-291.
13. X.M. Yin, Z.N. Oltvai and S.J. Korsmeyer, BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature 369 (1994), 321-333.
14. H. Zha, C. Aimé-Sempé, T. Sato and J.C. Reed, Pro-apoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2, J. Biol. Chem. 271 (1996), 7440-7444.
15. L, Cell 87 (1996), 619-628.